| Literature DB >> 26117661 |
Anna Schwendeman1, Denis O Sviridov2, Wenmin Yuan1, Yanhong Guo3, Emily E Morin1, Yue Yuan4, John Stonik2, Lita Freeman2, Alice Ossoli2, Seth Thacker2, Salena Killion5, Milton Pryor2, Y Eugene Chen3, Scott Turner5, Alan T Remaley2.
Abstract
The goal of this study was to understand how the reconstituted HDL (rHDL) phospholipid (PL) composition affects its cholesterol efflux and anti-inflammatory properties. An ApoA-I mimetic peptide, 5A, was combined with either SM or POPC. Both lipid formulations exhibited similar in vitro cholesterol efflux by ABCA1, but 5A-SM exhibited higher ABCG1- and SR-BI-mediated efflux relative to 5A-POPC (P < 0.05). Injection of both rHDLs in rats resulted in mobilization of plasma cholesterol, although the relative potency was 3-fold higher for the same doses of 5A-SM than for 5A-POPC. Formation of preβ HDL was observed following incubation of rHDLs with both human and rat plasma in vitro, with 5A-SM inducing a higher extent of preβ formation relative to 5A-POPC. Both rHDLs exhibited anti-inflammatory properties, but 5A-SM showed higher inhibition of TNF-α, IL-6, and IL-1β release than did 5A-POPC (P < 0.05). Both 5A-SM and 5A-POPC showed reduction in total plaque area in ApoE(-/-) mice, but only 5A-SM showed a statistically significant reduction over placebo control and baseline (P < 0.01). The type of PL used to reconstitute peptide has significant influence on rHDL's anti-inflammatory and anti-atherosclerosis properties.Entities:
Keywords: apolipoprotein A-I; atherosclerosis; high density lipoprotein; inflammation; peptides; sphingomyelin
Mesh:
Substances:
Year: 2015 PMID: 26117661 PMCID: PMC4548777 DOI: 10.1194/jlr.M060285
Source DB: PubMed Journal: J Lipid Res ISSN: 0022-2275 Impact factor: 5.922